Hycamtin Capsules and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Hycamtin Capsules and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: topotecan
Brand name: Hycamtin
Synonyms: Topotecan (oral/injection), Topotecan
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hycamtin Capsules-Insulin degludec
- Hycamtin Capsules-Insulin Degludec (U-100) Prefilled Pens
- Hycamtin Capsules-Insulin Degludec (U-100) Vials
- Hycamtin Capsules-Insulin Degludec (U-200) Prefilled Pens
- Hycamtin Capsules-Insulin degludec and liraglutide
- Hycamtin Capsules-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Hycamtin Intravenous
- Insulin aspart, recombinant Subcutaneous-Hycamtin oral/injection
- Insulin aspart, recombinant Subcutaneous-Hycet
- Insulin aspart, recombinant Subcutaneous-Hycodan
- Insulin aspart, recombinant Subcutaneous-Hycodan Oral
- Insulin aspart, recombinant Subcutaneous-Hycodan Oral Solution